1. Home
  2. SLNO vs TTAM Comparison

SLNO vs TTAM Comparison

Compare SLNO & TTAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • TTAM
  • Stock Information
  • Founded
  • SLNO 1999
  • TTAM 1902
  • Country
  • SLNO United States
  • TTAM Belgium
  • Employees
  • SLNO N/A
  • TTAM N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • TTAM
  • Sector
  • SLNO Health Care
  • TTAM
  • Exchange
  • SLNO Nasdaq
  • TTAM NYSE
  • Market Cap
  • SLNO 2.3B
  • TTAM 2.3B
  • IPO Year
  • SLNO 2014
  • TTAM 2025
  • Fundamental
  • Price
  • SLNO $71.99
  • TTAM $13.16
  • Analyst Decision
  • SLNO Strong Buy
  • TTAM Strong Buy
  • Analyst Count
  • SLNO 8
  • TTAM 5
  • Target Price
  • SLNO $92.00
  • TTAM $17.20
  • AVG Volume (30 Days)
  • SLNO 1.8M
  • TTAM 448.0K
  • Earning Date
  • SLNO 05-08-2025
  • TTAM 03-26-2025
  • Dividend Yield
  • SLNO N/A
  • TTAM N/A
  • EPS Growth
  • SLNO N/A
  • TTAM 180.40
  • EPS
  • SLNO N/A
  • TTAM 0.95
  • Revenue
  • SLNO N/A
  • TTAM $1,634,393,000.00
  • Revenue This Year
  • SLNO N/A
  • TTAM N/A
  • Revenue Next Year
  • SLNO N/A
  • TTAM N/A
  • P/E Ratio
  • SLNO N/A
  • TTAM $13.92
  • Revenue Growth
  • SLNO N/A
  • TTAM 41.82
  • 52 Week Low
  • SLNO $36.61
  • TTAM $12.61
  • 52 Week High
  • SLNO $73.97
  • TTAM $17.78
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 84.44
  • TTAM N/A
  • Support Level
  • SLNO $48.29
  • TTAM N/A
  • Resistance Level
  • SLNO $51.88
  • TTAM N/A
  • Average True Range (ATR)
  • SLNO 3.03
  • TTAM 0.00
  • MACD
  • SLNO 2.32
  • TTAM 0.00
  • Stochastic Oscillator
  • SLNO 93.61
  • TTAM 0.00

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About TTAM TITAN AMERICA SA

Titan America SA is a vertically integrated, multi-regional manufacturer and supplier of heavy building materials and services operating primarily on the Eastern Seaboard. The Company, through its wholly owned subsidiaries, primarily operates in the manufacture, distribution, and sale of cement, fly ash, aggregates, ready-mix concrete, and concrete blocks to resellers and construction contractors in the Eastern region of the United States.

Share on Social Networks: